Previous close | 20.24 |
Open | 20.30 |
Bid | 20.50 x 200 |
Ask | 20.54 x 100 |
Day's range | 19.94 - 20.78 |
52-week range | 14.56 - 33.31 |
Volume | |
Avg. volume | 1,211,903 |
Market cap | 2.925B |
Beta (5Y monthly) | 1.39 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.94 |
Earnings date | 06 Aug 2024 - 12 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 39.69 |
The latest analyst coverage could presage a bad day for Denali Therapeutics Inc. ( NASDAQ:DNLI ), with the analysts...
Denali Therapeutics ( NASDAQ:DNLI ) First Quarter 2024 Results Key Financial Results Net loss: US$101.8m (loss narrowed...
Denali (DNLI) Q1 loss narrows year over year due to lower expenses despite nil revenues.